Prevention of side-effects of interferon.
Visco
G
G
Boumis
E
E
Noto
P
P
Comandini
U V
UV
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D007251:Influenza, Human / Q000517:prevention & control; D007370:Interferon Type I / Q000009:adverse effects*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011282:Pregnenediones / Q000627:therapeutic use*; D011994:Recombinant Proteins
D000893:Anti-Inflammatory Agents; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011282:Pregnenediones; D011994:Recombinant Proteins; C021988:deflazacort